Formulation and Development of HA BSA Coated NLC Containing Fisetin and Flavokawain A for the Treatment of Lung Carcinoma. JOC [Internet]. 2025 Oct. 8 [cited 2025 Dec. 26];24(8s):553-62. Available from: https://carcinogenesis.com/index.php/JOC/article/view/1319